Loss of 123I-MIBG uptake by the heart in Parkinson's disease: Assessment of cardiac sympathetic denervation and diagnostic value

Journal of Nuclear Medicine

Volumn 40, Issue 3, 1999, Pages 371-375

  Satoh, Akira ^a,b   Serita, Takumi ^a   Seto, Makiko ^a   Tomita, Itsuro ^a   Satoh, Hideyo ^a   Iwanaga, Keisuke ^a   Takashima, Hidetoshi ^a   Tsujihata, Mitsuhiro ^a  

^a Nagasaki Kita Hospital   (Japan)

^b Nagasaki City Hospital   (Japan)

Author keywords

Autonomic function; Metaiodobenzylguanidine; Parkinson's disease; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ANTIPARKINSON AGENT; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENERVATION; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG CLEARANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SCINTISCANNING; CENTRAL NERVOUS SYSTEM DISEASE; HEART; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032588267     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aminoff MJ, Wilcox CS. Assessment of autonomic function in patients with a parkinsonian syndrome. BMJ. 1971;4:80-84.
2. McDowell KH, Lee JE, Levedopa, Parkinson's disease and hypotension. Ann Intern Med. 1970;72:751-752.
3. Calne DB, Brennan J, Spiers ASD, Stern GM. Hypotension caused by L-dopa. BMJ. 1970;1:474-475.
4. Vanderhacgen JJ, Perrier O, Srernon JE. Pathological findings in idiopathic orthostatic hypotension. Anch. Neurol. 1970;22:207-214.
5. Micieli G, Martignoni E, Cavallini A, et al. Postprandial and orthostatic hypotension in Parkinson's disease. Neurology. 1987;37:386-393.
6. Den Hartog Jager WA, Bethrem J. The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry. 1960;23:283-290.
7. Rajput AH, Rozdilky B. Dysautonomia in Parkinsonism: clinico-pathological study. J Neurosurg Psychiatry. 1976;39:1092-1100.
8. Wieland DM, Brown LE, Rogers L, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31.
9. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123-metaiodobenzylguanidine. J Nucl Med. 1981;22:129-132.
10. Dae MW, O'Connel JW, Botvinick EH, et al. Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation. 1989;79:634-644.
11. Nakala T, Shimamoto K, Yonekura S, et al. Cardiac sympathetic denervation in transthyrelin-related familial amyloidotic polyneuropathy: detection with iodine-123-MIBG. J Nucl Med. 1995;36:1040-1042.
12. Seisson JC, Schapiro B, Mayer L, et al. Metaiodobenzyl-guanidine to map seintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625-1636.
13. Langer A, Freeman MR, Josse RD, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol. 1995;25:610-618.
14. 123I-myocardial scintigraphical analysis in patients with and without autonomic disorder. Clin Neurol. 1994;34:402-404.
15. Scrita T, Irita A, Ueyama C, et al. Autonomic nervous function of the heart in patient with Parkinson's disease. Ther Res. 1995;16:60-64.
16. Tobes MC, Jaques S Jr. Wieland DM, Sisson JC. Effect of uptake-one inhihitors on the uptake of norepinephrine and metaiodobenzylguianidine. J Nucl Med. 1985;26:897-907.
17. Minardo JD, Tuli MM, Moch BH, et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and innervation produced by myocardial infarction or phenol application. Circulation. 1988;78: 1008-1019.
18. Stanlon MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using 1-123-metaiodobenzylguanidine. J Am Coll Cardiol. 1989;14:1519-1526
19. Marco TD, Dae M, Yuen-Green MSF, et al. Iodine-123 metaidobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol. 1995;25:927-931.
20. Carrio I. Estorch M, Berna L, et al. Iodine-III-antimyosine and iodine-123-MIBG studies in early assessment of doxorubicin cardiomyopathy. J Nucl Med. 1995;36:2044-2049.
21. Wakasugi S, Inoue M, Tazawa S. Assessment of adreneryic neuron function altered with progression of heart failure. J Nucl Med. 1995;36:2069-2074.
22. Wakabayashi K, Takahasi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. In: Ikuta F. ed. Neuropathology in Brain Research. Amsterdam, The Netherlands: Excerpta Medica: 1991;133-141.
23. Wakabayashi K. Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system. Brain Nerve 1993;45:965-971.